Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients
- PMID: 10817650
- DOI: 10.1002/(sici)1096-8628(20000529)92:3<170::aid-ajmg3>3.0.co;2-#
Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients
Abstract
Mutations at the ataxia-telangiectasia (A-T) locus on chromosome band 11q22 cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer, ischemic heart disease, and early mortality. PCR amplification from genomic DNA and automated sequencing of the entire coding region (66 exons) and splice junctions detected 77 mutations (85%) in 90 A-T chromosomes. Heteroduplex analysis detected another 42 mutations at the A-T locus. Out of a total of 71 unique mutations, 50 were found only in a single family, and 51 had not been reported previously. Most (58/71, 82%) mutations were frameshift and nonsense mutations that are predicted to cause truncation of the A-T protein; the less common mutation types were missense (9/71, 13%), splicing (3/71, 4%) and one in-frame deletion, 2546 3 (1/71, 1%). The mean survival and height distribution of 134 A-T patients correlated significantly with the specific mutations present in the patients. Patients homozygous for a single truncating mutation, typically near the N-terminal end of the gene, or heterozygous for the in-frame deletion 2546 3, were shorter and had significantly shorter survival than those heterozygous for a splice site or missense mutation, or heterozygous for two truncating mutations. Alterations of the length or amino acid composition of the A-T gene product affect the A-T clinical phenotype in different ways. Mutation analysis at the A-T locus may help estimate the prognosis of A-T patients.
Similar articles
-
Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.Neuromolecular Med. 2013 Sep;15(3):536-40. doi: 10.1007/s12017-013-8240-3. Epub 2013 Jun 27. Neuromolecular Med. 2013. PMID: 23807571 Free PMC article.
-
Mutations associated with variant phenotypes in ataxia-telangiectasia.Am J Hum Genet. 1996 Aug;59(2):320-30. Am J Hum Genet. 1996. PMID: 8755918 Free PMC article.
-
Comprehensive scanning of the ATM gene with DOVAM-S.Hum Mutat. 2003 Feb;21(2):123-31. doi: 10.1002/humu.10158. Hum Mutat. 2003. PMID: 12552559
-
Ataxia telangiectasia gene mutations in leukaemia and lymphoma.J Clin Pathol. 2001 Jul;54(7):512-6. doi: 10.1136/jcp.54.7.512. J Clin Pathol. 2001. PMID: 11429421 Free PMC article. Review.
-
Ataxia-telangiectasia, an evolving phenotype.DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1187-96. doi: 10.1016/j.dnarep.2004.04.010. DNA Repair (Amst). 2004. PMID: 15279807 Review.
Cited by
-
High risk factors of pancreatic carcinoma.J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):295-304. doi: 10.1007/s11596-016-1583-x. Epub 2016 Jul 5. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27376795 Review.
-
A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.Hum Mol Genet. 2015 Nov 15;24(22):6331-49. doi: 10.1093/hmg/ddv342. Epub 2015 Aug 26. Hum Mol Genet. 2015. PMID: 26310626 Free PMC article.
-
Ataxia telangiectasia: a review.Orphanet J Rare Dis. 2016 Nov 25;11(1):159. doi: 10.1186/s13023-016-0543-7. Orphanet J Rare Dis. 2016. PMID: 27884168 Free PMC article. Review.
-
Critical DNA damaging pathways in tumorigenesis.Semin Cancer Biol. 2022 Oct;85:164-184. doi: 10.1016/j.semcancer.2021.04.012. Epub 2021 Apr 24. Semin Cancer Biol. 2022. PMID: 33905873 Free PMC article. Review.
-
Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.Sci Rep. 2019 Dec 27;9(1):19986. doi: 10.1038/s41598-019-55515-x. Sci Rep. 2019. PMID: 31882575 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases